PH94B in the Treatment of Adjustment Disorder With Anxiety
Trial details
- Registry ID
- NCT04404192
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Aloradine
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| PH94B in the Treatment of Adjustment Disorder With AnxietyNCT04404192 | VTGN | Phase 2 | Completed | 2022-12-14Actual |
| Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)NCT05030350 | VTGN | Phase 3 | Terminated | 2022-09-23Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |